2002
Requests for reprints can be addressed to:
de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW
Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique
Int J Pharm, 249, 219-231, 2002
de Boer AH, Gjaltema D, Hagedoorn P, Schaller M, Witt W, Frijlink HW
Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols
Int J Pharm, 249, 233-245, 2002
de Boer AH, Le Brun PPH, van der Woude HG, Hagedoorn P, Heijerman HGM, Frijlink HW
Dry powder inhalation of antibiotics in cystic fibroses therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle
Eur J Pharm Biopharm, 54, 17-24, 2002
Le Brun PPH, de Boer AH, Mannes GPM, Fraîture DMI, Brimicombe RW, Touw DJ, Vinks AA, Frijlink HW, Heijerman HGM
Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 2: inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients
Eur J Pharm Biopharm, 54, 25-32, 2002
Le Brun PPH, de Koning JP, de Boer AH, Frijlink HW, Heijerman HGM
Dry powder inhalers
J Cystic Fibrosis I, S5-S34, p. S27
Dickhoff BHJ, Ellison MJH, de Boer AH, Frijlink HW
The effect of budesonide particle mass on drug particle detachment from carrier crystals in adhesive mixtures during inhalation
Eur J Pharm Biopharm, 54, 245-248, 2002
van Doorne H, Boom FA
Plan van aanpak voor product en proces
Eissens AC, Bolhuis GK, Hinrichs WLJ, Frijlink HW
Inulin as filler-binder for tablets prepared by direct compression
Eur J Pharm Sci, 15, 31-38, 2002
Eriksson HJC, Hinrichs WLJ, van Veen B, Somsen GW, de Jong GJ, Frijlink HW
Investigations into the stabilisation of drugs by sugar glasses: I. Tablets prepared from stabilised alkaline phosphatase
Frijlink HW, Hagedoorn P, Gjaltema D, Goede J, de Boer AH
An air classifier principle for effective de-agglomeration of inhalation powders
Proceedings Respiratory Drug Delivery VIII, Vol II, 451-453, 2002
Fyrnys B, Mueller S, de Boer AH, Wolf-Heuss E
Performace characteristics of the NovolizerTM with respect to the draft guidance for industry for metered dose inhaler and dry powder inhaler drug products
Proceedings Respiratory Drug Delivery VIII, Vol II, 603-606, 2002
de Koning JP, van der Mark TW, Coenegracht PMJ, Tromp TFJ, Frijlink HW
Effect of an external resistance to airflow on the inspiratory flow curve
Int J Pharm, 234, 257-266, 2002
Kuipers ME, Heegsma J, Bakker HI, Meijer DKF, Swart PJ, Frijlink HW, Eissens AC, de Vries-Hospers HG, van den Berg JJM
Design and fungicidal activity of mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis
van Santen E, Barends DM, Frijlink HW
Breaking of scored tablets: a review
Eur J Pharm Biopharm, 53, 139-145, 2002
Stuurman-Bieze AGG, de Koning JP
Fouten, instructies, ontwikkelingen
van Veen B, van der Voort Maarschalk K, Bolhuis GK, Visser MR, Zuurman K, Frijlink HW
Pore formation in tablets compressed from binary mixtures as a result of deformation and relaxation of particles
Eur J Pharm Sci, 15, 171-177, 2002
van Veen B, van der Voort Maarschalk K, Bolhuis GK, Gons M, Zuurman K, Frijlink HW
The influence of particles of a minor component on the matrix strength of sodium chloride
Eur J Pharm Sci, 16, 229-235, 2002
Weda M, Zanen P, de Boer AH, Gjaltema D, Ajaoud A, Barends DM, Frijlink HW
Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy
Int J Pharm, 249, 247-255, 2002
Zijlstra GS, Hagedoorn P, Hinrichs WLJ, de Boer AH, Frijlink HW
Effective powder de-agglomoration principle enables the application of classical dry powder formulation techniques for peptides in inhalation
Proceedings Respiratory Drug Delivery VIII, Vol. II, 455-457, 2002
| Laatst gewijzigd: | 22 november 2012 16:48 |